Xeriant Defaults on Debt Settlement, Faces Imminent Cash Shortage Amidst Going Concern Warning
XERI has more than doubled off its 52-week low of $0.004 on elevated volume (5.6× avg).
Summary
Xeriant, Inc. is in default on a $3.5 million debt settlement and faces a critical two-month cash runway, reiterating its 'going concern' warning despite a non-cash accounting gain.
Key Events · Legal and Risk Events · XERI
-
Going Concern Warning & Critical Cash Runway
The company reiterated its 'going concern' warning, stating it expects to expend its available cash in approximately two months from May 15, 2026. It reported a working capital deficit of $5.8 million as of March 31, 2026, and a cash balance of only $24,560.
-
Default on Debt Settlement Agreement
Xeriant is in default on its $3.5 million cash payment obligations under a settlement agreement with Auctus Fund LLC, which was effective October 29, 2025. The company has not made any cash payments related to this agreement as of March 31, 2026.
-
Net Income Driven by Non-Cash Gain
The reported net income of $1.51 million for the nine months ended March 31, 2026, was primarily due to a $2.74 million non-cash gain on the extinguishment of debt from the Auctus settlement. The company still recorded a net loss of $419,393 for the three months ended March 31, 2026.
-
Continued Share Dilution
During the nine months ended March 31, 2026, the company issued 59.51 million common shares from convertible note conversions and 30 million shares for the Auctus settlement. Additionally, 84.6 million new warrants were issued with convertible notes.
Analysis · XERI · Manufacturing
Xeriant, Inc. is in severe financial distress, having defaulted on a $3.5 million cash payment obligation under a debt settlement agreement with Auctus Fund LLC. This default, coupled with a reiterated 'going concern' warning and a critical two-month cash runway, highlights the company's precarious liquidity position. While the company reported a net income for the nine-month period, this was primarily due to a non-cash gain from the debt extinguishment, and the most recent quarter still showed a net loss. The ongoing significant dilution from convertible notes and warrants further pressures existing shareholders. Although a patent allowance for its NEXBOARD technology is a positive development, it does not address the immediate and critical financial challenges.
At the time of this filing, XERI was trading at $0.03 on OTC in the Manufacturing sector, with a market capitalization of approximately $22.3M. The 52-week trading range was $0.00 to $0.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.